Title: Antibiotics Resistance among Major Foodborne Bacterial Pathogens
Author: Dr. Adnan Bashir Bhatti, M.D.
DOI: http://dx.doi.org/10.18535/jmscr/v4i7.03
Abstract
Bacteria-mediated food poisoning is a major contributing factor for the increase in a total number of hospital visits, stays, and emergency room (ER) visits among otherwise healthy people. In most cases, bacterial food poisoning is self-limiting in healthy adults; however, the condition often requires medical interventions in children and immunocompromised patients. Salmonella, Escherichia coli, Staphylococcus aureus, Campylobacter, Vibrio, Listeria monocytogenes and Shigella are the major bacterial pathogens that are responsible for food poisoning. One of the major challenges faced by physicians with food poisoning cases is the emergence of antibiotic resistance which renders antibiotic treatment ineffective. The following review addresses these issues with a brief overview of each pathogen, the major reasons for the emergence of antibiotic resistance, and suggestions on how we can prevent the incidence of antibiotic resistance.
References
1. Singh SB, Barrett JF. Empirical antibacterial drug discovery—Foundation in natural products. Biochem Biochem Pharmacol. 2006; 71:1006–1015.
2. Barriere SL. Clinical, economic and soci-etal impact of antibiotic resistance. Expert Opin Pharmacother.2015;16, 151-153.
3. Ruppé É, Woerther P-L, Barbier F. Mechanisms of antimicrobial resistance in Gram-negative bacilli. Ann Intensive Care. 2015;5:21.
4. Byarugaba DK. Mechanisms of Antimicrobial Resistance. In Sosa AJ, l Byarugaba DK, Ama´bile-Cuevas CF, Hsueh P, Kariuki l S, Okeke IN, editors. Antimicrobial Resistance in Developing Countries [internet]. New York: Springer ; 2009 [cited 2016 Feb 9]. 15-26 p. Available from https://www.researchgate. net/profile/Eric_Mitema/publication/ 226946093_The_Role_of_Unregulated_Sale_and_Dispensing_of_Antimicrobial_Agents_on_the_Development_of_Antimicrobial_Resistance_in_Developing_Countries/links/5513b1110cf2eda0df30288c.pdf. DOI 10.1007/978-0-387-89370-9_2.
5. WHO. Food safety Fact sheet N°399. 2015. Cited 2015 Dec 30: http://www. who.int/mediacentre/factsheets/fs399/en/.
6. Rahul P, Jha SN, Mishra VK. Identification of Salmonella strains of phyllosphere food poisoning by melt curve analysis: In silico approach. Int J Computational Biol.2015; 4, 38-43.
7. Majowicz SE, Musto J, Scallan E, Angulo FJ, Kirk M, O’Brien SJ, et al. The global burden of nontyphoidal Salmonella gastroenteritis. Clin Infect Dis. 2010; 50, 882-889.
8. Centers for disease control and prevention: Salmonella. 2015. Cited 2015 Dec 30. http://www.cdc.gov/salmonella/.
9. Linam WM, Gerber MA. Changing epidemiology and prevention of Salmonella infections. Pediatr Infect Dis J. 2007; 26, 747–748.
10. Chen Z, Zhang Ke, Yin H, Li, Lan Wang, Zhiguo Liu . Detection of Salmonella and several common Salmonella serotypes in food by loop-mediated isothermal amplification method. Food sci human wellness. 2015; 4, 75–79.
11. WHO.Salmonella (non typhoidal ) 2015. Cited 2015 Dec 30 http://www. who.int/mediacentre/factsheets/fs139/en/
12. Voetsch AC, Van Gilder TJ, Angulo FJ, Farley MM, Shallow S,Marcus R, et al. FoodNet estimate of the burden of illness caused by nontyphoidal Salmonella infections in the United States. Clin Infect Dis. 2004; 38,127-34.
13. Committee on infectious diseases: Salmonella infections. In Pickering LK, Baker CJ, Long SS, McMillan JA, editors. Red Book: 2006 Report of the committee on infectious diseases. 2006. American Academy of Pediatrics, Elk Grove Village, IL; 27:579 -583
14. Su LH, Chiu CH, Chu C, Ou TJ. Antimicrobial resistance in non-typhoid Salmonella serotypes: A global challenge. Clin Infect Dis. 2004; 39,546-551.
15. Mølbak K, Baggesen DL, Aarestrup FM, Ebbesen JM, Engberg J, Frydendahl K ,et al. An outbreak of multidrug-resistant, quinolone-resistant Salmonella enterica serotype Typhimurium DT104. N Engl J Med. 1999; 341,1420-1425.
16. Crump JA, Barrett TJ, Nelson JT, Angulo FJ. Reevaluating fluoroquinolone breakpoints for Salmonella enterica serotype Typhi and for non-Typhi salm-onllae. Clin Infect Dis. 2003, 37:75-79.
17. Falkow S. Escherichia coli and Salmonella typhimurium. In Neidhardt FC, editor. Cellular and Molecular Biology, 1996. ASM, Washington DC, 2723 p . Trends Microbiol. 4, 430.
18. Centers for disease control and prevention.2015, E. coli. General Information. 2015. Cited 2015 Dec 30. http://www.cdc.gov/ecoli/general/
19. Croxen MA, Law RJ, Scholz R, Keeney KM, Wlodarska M, Finlay BB. Recent advances in understanding enteric pathogenic Escherichia coli. Clin Microbiol Rev. 2013; 26:822–880.
20. Lopes LM, Fabbricotti SH, Ferreira AJP, Kato MAMF, Michalski J, Scaletsky ICA Heterogeneity among strains of diffusely adherent Escherichia coli isolated in Brazil. J Clin Microbiol.05; 43,1968-1972.
21. Tariq A, Haque A, Ali A, Bashir S, Habeeb MA, Salman M, et al. Molecular profiling of antimicrobial resistance and integron association of multidrug-resistant clinical isolates of Shigella species from Faisalabad, Pakistan. Canadian J Microbiol. 2012;58,1047-1054
22. Goel N, Wattal C, Kaul D, Khanna VK, 2013. Emergence of ceftriaxone resistant Shigella. Indian J. Pediatr. 80:70–71.
23. Sjölund KM, Bowen A, Reporter R, Folster JP, Grass JE, Howie RL, et al. Outbreak of infections caused by Shigella sonnei with reduced susceptibility to azithromycin in the United States. Antimicrob. Agents Chemother. 2013;57,1559–1560.
24. Ogura Y, Ooka T, Iguchi A, Toh H, Asadulghani M, Oshima K, et al. Comparative genomics reveal the mechanism of the parallel evolution of O157 and non-O157 enterohemor-rhagic Escherichia coli. Proc Natl Acad Sci USA.2009; 106, 17939–17944.
25. Venturini C, Beatson SA, Djord-jevic SP, Walker MJ. Multiple antibiotic resistance gene recruitment onto the enterohemorrhagic Escherichia coli virulence plasmid. FASEB J. 2010; 24,1160–1166.
26. Kluytmans JAJW, Wertheim HFL. Nasal carriage of Staphylococcus aureus and prevention of nosocomial infections. Infection. 2005; 33, 3–8.
27. Hennekinne JA, De Buyser ML, Dragacci S. Staphylococcus aureus and its food poisoning toxins: characterization and outbreak investigation. FEMS Microbiol Rev. 2012; 36, 815–836.
28. Tranter HS. Foodborne staphylococcal illness. Lancet. 1990; 336, 1044–1046.
29. Balaban N, Rasooly A. Staphylococcal enterotoxins. Int J Food Microbiol. 2000; 61, 1–10.
30. Murray RJ. Recognition and management of Staphylococcus aureus toxin-mediated disease. Intern Med J. 2005; 2,S106–S119.
31. Centers for disease control and prevention. Staphylococcal Food Poisoning. 2010. Cited 2015 Dec 30.
http://www.cdc.gov/nczved/divisions/dfbmd/diseases/staphylococcal/
32. Argudín MÁ, Mendoza MC, Rodicio MR. Food Poisoning and Staphylococcus aureus Enterotoxins. Toxins. 2010;2, 1751-1773.
33. Okuyama Y, Yoshida N. Staphylococcal food poisoning and MRSA enterocolitis. Nihon Rinsho. 2012; 70, 1362-1365.
34. Jones TF, Kellum ME, Porter SS, Bell M, Schaffner W. An Outbreak of Community-Acquired Foodborne Illness Caused by Methicillin-Resistant Staphylococcus aureus. Emer Infect Dis. 2002;8, 82-84.
35. Rhee CH, Woo GJ. Emergence and Characterization of foodborne Methicillin-Resistant Staphylococcus aureus in Korea J Food Prot. 2010, 6, 2148-2349.
36. Harris NV, Weiss NS, Nolan CM. The role of poultry and meats in the etiology of Campylobacter jejuni/coli enteritis. Am J Public Health. 1986; 76, 407-411.
37. Cason JA , Bailey JS, Stern NJ, Wittenmore AD, Cox NA. Relationship between aerobic bacteria, salmonellae and Campylobacteron broiler carcasses. Poult. Sci.1997; 76, 1037-1041.
38. Centers for disease control and prevention. National Center for Emerging and Zoonotic Infectious Diseases . Campylobacter. 2014. Cited 2015 Dec 20. http://www.cdc.gov/nczved/divisions/dfbmd/diseases/campylobacter/
39. Altekruse SF, Stern NJ, Fields PI, Swerdlow DL. Campylobacter jejuni—An emerging foodborne pathogen,” Emerg Infect Dis. 1999; 5, 28-35.
40. Smith, KE, Besser JM, Hedberg CW, Leano FT, Bender JB, Wicklund JH, et al. Quinolone-resistant Campylobacter jejuni infections in Minnesota, 1992-1998. New Eng J Med, 1999; 340,1525-1532.
41. Blaser, MJ. Epidemiologic and Clinical Features of Campylobacter jejuni Infec-tions. J Infect Dis. 1997; 176, S103-105.
42. Lee CY, Tai CL, Lin SC, Chen YT. Occurrence of plasmids and tetracycline resistance among Campylobacter jejuni and Campylobacter coli isolated from whole market chickens and clinical samples. Int J Food Microbiol. 1994; 24, 161–170.
43. Piddock L J, Ricci V, Pumbwe L , Everett MJ, Griggs DJ. Fluoroquinolone resistance in Campylobacter species from man and animals: detection of mutations in topoisomerase genes. J Antimicrob Chemother. 2003; 51,19-26.
44. Wardak S, Szych J, Zasada AA, Gierczyński R. Antibiotic Resistance of Campylobacter jejuni and Campylobacter coli clinical isolates from Poland. Antimic-rob Agents Chemother. 07; 51, 1123-1125.
45. Gibreel A, Tracz DM, Nonaka L, Ngo TM, Connell SR, Taylor DE. Incidence of antibiotic resistance in Campylobacter jejuni isolated in Alberta, Canada, from 1999 to 2002, with special reference to tet (O)-mediated tetracycline resistance. Antimicrob Agents Chemother. 2004; 48, 3442-3450.
46. Chiou A, Chen LH., Chen SK. Foodborne illness in Taiwan, 1981–1989. Airiti library. 1991; 43, 452 - 453.
47. Rosec JP, Causse V, Cruz B, Rauzier J, Carnat L. The international standard ISO/TS 21872-1 to study the occurrence of total and pathogenic Vibrio parahaemolyticus and Vibrio cholerae in seafood: ITS improvement by use of a chromogenic medium and PCR. Int J Food Microbiol. 2012; 157,189-194.
48. Centers for disease control and prevention: Cholera - Vibrio cholerae infection: Antibiotic treatment. (2013). Accessed: 12/30/2015. : http://www.cdc.gov/cholera /treatment/antibiotic-treatment.html.
49. Centers for disease control and prevention: Cholera - Vibrio cholerae infection: Gen-eral information. 2014. Cited 2015 Dec 30 . http://www.cdc.gov/cholera/general/.
50. Sperling L, Alter T, Huehn S. Prevalence and Antimicrobial Resistance of Vibrio spp. in retail and farm shrimps in Ecuador. J Food Prot. 2015; 78, 2089-2092.
51. Dong C, Zhang X, Bao C, ZhuY, Zhuang L, Tan Z, et al. Antibiotic resistance and molecular characterization of Vibrio cholera strains isolated from an outbreak of cholera epidemic in Jiangsu province. Zhonghua Yu Fang Yi Xue Za Zhi [Chinese Journal of Preventive Medicine]. 2015; 49, 128–131.
52. Farber JM, Peterkin PI. Listeria monocytogenes, a food-borne pathogen. Microbiol Rev. 1991; 55, 476–511.
53. Temple ME, Nahata MC. Treatment of listeriosis. Ann Pharmacother. 2000; 34:656–661.
54. Hof H. An update on the medical management of listeriosis. Expert Opin Pharmacother. 2004; 5, 1727-1735.
55. Godreuil S, Galimand M, Gerbaud G, Jacquet C, Courvalin P. Efflux pump Lde is associated with fluoroquinolone resistance in Listeria monocytogenes. Antimicrob Agents Chemother. 2003; 47, 704–708.
56. Poyart-Salmeron C, Carlier C, Trieu-Cuot P, Courtieu AL, Courvalin P. Transferable plasmid-mediated antibiotic resistance in Listeria monocytogenes. Lancet. 1990; 335,1422–1426.
57. Safdar A, Armstrong D. Antimicrobial activities against 84 Listeria monocytogenes isolates from patients with systemic listeriosis at a comprehensive cancer center (1955-1997). J Clin Microbiol. 2003; 41, 483-485.
58. Scallan E, Hoekstra RM, Angulo FJ, Tauxe RV, Widdowson MA, Roy SL ,et al. Foodborne illness acquired in the United States--major pathogens. Emerg Infect Dis. 2011; 17,7-15.
59. Niyogi SK. Shigellosis. J Microbiol.2005; 43,133–143.
60. Adams DA, Jajosky RA, Ajani U, Kriseman J, Sharp P, Onwen DH, et al.Summary of notifiable diseases -United States, 2012. MMWR Morb Mortal Wkly Rep. 2014; 61, 1-121.
61. Watson, JT, Jones RC, Fernandez J, Cortes C, Gerber SI, Kuo KJ, et al. Shigella flexneri serotype 3 infections among men who have sex with men--Chicago, Illinois, 2003-2004. MMWR Morb Mortal Wkly Rep. 2005; 54, 820-822.
62. CDC. Panel on Opportunistic Infections in HIV-Infected Adults and Adolescents. Guidelines for the prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from the Centers for Disease Control and Prevention, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. US Department of Health and Human Services. 2015. [cited 2015 Mar 27]. http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf.
63. Ye C, Lan R, Xia S, Zhang J, Sun Q, Zhang S, et al. Emergence of a new multidrug-resistant serotype X variant in an epidemic clone of Shigella flexneri. J Clin Microbiol. 2010; 48, 419–426.
64. MoezArdalan K, Zali MR, Dallal MM, Hemami MR, Salmanzadeh-Ahrabi S. Prevalence and pattern of antimicrobial resistance of Shigella species among patients with acute diarrhea in Karaj Tehran, Iran J Healt.h Popul Nutr . 2003; 21, 96–102.
65. Wasfy MO, Oyofo BA, David JC, Ismail TF, el-Gendy AM, Mohran ZS, et al. Isolation and antibiotic susceptibility of Salmonella, Shigella, and Campylobacter from acute enteric infections in Egypt. J Health Popul Nutr. 2000; 18, 33–38.
66. World Health Organization Department of Communicable Disease Surveillance and Response. WHO global strategy for containment of antimicrobial resistance. Geneva: WHO. 2001. Cited 2015 Dec 30. http://www.who.int/drugresistance/WHO_Global_Strategy.htm/en/
67. Kumar SG, Adithan C, Harish BN, Sujatha S, Roy G, Malini A. Antimicrobial resistance in India: A review. J Nat Sci Biol Med. 2013;4, 286-291.
68. Levy S. Reduced antibiotic use in livestock: How Denmark tackled resistance. Environ Health Perspect. 2014;122, A160-A165
69. Cantón R, Morosini MI. Emergence and spread of antibiotic resistance following exposure to antibiotics. FEMS Microbiol reviews. 2011; 35, 977–991.
70. Levy SB. Factors impacting on the problem of antibiotic resistance. J Antimicrob Chemother. 2002; 49, 25-30.
71. Allen HK, LevineUY, Looft T, Bandrick M, Casey TA. Treatment, promotion, commotion: antibiotic alternatives in food-producing animals. Trends Microbiol. 2013; 21, 114-119.